The neurological manifestations of Wilson's disease can vary extremely and they are often diagnosed after long delays. 4 Here, we are reporting Wilson's disease with neurological & hepatic presentations in a 13 years girl.
Case Report:
13 years old Bangladeshi girl presented to us with C/O involuntary movement of neck, hands & legs in the form of repetitive purposeless abnormal movements associated with abnormal psychological behavior like restlessness, agitation & emotional variation like sudden smiling or crying for last 3 years. She also complained of having wrist, elbow & knee joint pain for last 2 years. The T2(MRI) -weighted axial sequence through pons revealed the "face of the miniature panda", which was also suggestive of Wilson's disease (Fig 1) . The diagnosis of Wilson's disease was made on the basis of neurological manifestation like dystonia, ataxia, dysarthia, psychological behaviour, hepatic involvement & joint pain with the presence of the K-F ring in the both eyes, the low serum ceruloplasmin and the 24 hours urinary copper excretion. The patient was placed on oral zinc (as zinc acetate) at a dose of 1mg/kg/dose of elemental zinc 8 hourly and Trihexiphenidyl to control the dystonia. Oral haloperidol & perkinil for neuropsychiatric symptoms.She was advised to avoid food with a high copper content, such as chocolates, nuts, legumes, mushrooms, shellfish and liver. Her parents were also advised to avoid the use of copper utensils in the household for the storage of water and for cooking food.
After one week of treatment, we noticed improvement of symptoms of the patient. Dystonia reduced in intensity & psychiatric symptoms were improved. After two weeks, her joints become more mobile, involuntary movement reduced & dysphagia & jaundice improved but hepatomegaly was persistent. We advised her to continue treatment & come for further follow up after 2 weeks.
We also advised her to come to us with her sibling having similar manifestation for evaluation.
Discussion :
Wilson's Disease (WD) is a rare, autosomal recessive disease caused by a mutation in the copper-transporting gene, ATP7B. Copper first accumulates in the liver; after the liver storage capacity for copper gets saturated, copper gets redistributed, with accumulation in the nervous system, the cornea, the kidneys and other organs 5 . Most of the patients present in the second decade of life with a primary hepatic presentation, remainder of the patients usually present during the third and fourth decades, with a primarily neurologic or a psychiatric manifestation 6 . However, our case presented with neurological manifestations in the second decade of life (adolescent).The disease was found to manifest at a younger age in Indian children. This could be most likely due to higher average intake of copper in India, which ranges from 5.7 -7.1 mg/day and it is higher than the reported 0.34 -1.1 mg/day in the western countries. The practice of cooking food and storing drinking water in copper/copper alloy pots might be contributory . 7.
In Wilson's disease with neurological presentations, the symptoms are predominantly extra pyramidal, like dystonia, tremors, dysphasia, dysarthria, and ataxia. The neurological symptoms are usually secondary to the cerebral copper deposition, which is sufficient to destroy the nerve cells. Our case had neurological manifestations, predominantly dystonia, dysarthria and some cognitive impairment. The serum ceruloplasmin level should not be considered for making a definitive diagnosis, because they are normal in up to 10% of the affected patients and are reduced in 20% of the carriers. The Kayser -Fleischer rings can only be diagnosed definitively by an ophthalmologist by using a slit lamp. Urine copper is an important diagnostic tool but it must be collected carefully to avoid contamination. An estimation of the 24hour urinary copper excretion is another reliable test which can be done for the confirmation of WD. The normal excretion of copper is between 20 and 50µg per day.In cases of WD, excretion is increased to in excess of 100µg per day. The "Gold standard" for the diagnosis remains a liver biopsy with quantitative copper assays.
The affected people have values of > 200µg/gm dry weight of the liver. The copper stains are not reliable 8 . In our case, we had made the diagnosis on the basis of the clinical presentations, the serum ceruloplasmin levels, the 24 hours urinary copper excretion and neuroimaging (MRI). Although a liver biopsy with quantitative copper assay is the "Gold standard", due to the parents' refusal, liver biopsy was not done in our patient. MRI is a very sensitive method for revealing the abnormalities in WD. On the T1 -weighted sequence, hypointensities in the basal ganglia are seen in two-thirds of the cases while in the T2 -weighted images, hyperintensities in the basal ganglia, the white matter, the thalamus or the brainstem are seen. These abnormalities are caused by a neuronal loss, gliosis, degeneration of the fibres, and vacuolisation, which are associated with the increased water content in the brain. The typical 'face of the giant panda' can be seen in the midbrain on the T2 -weighted axial MRI sequence of the brain and the 'face of the miniature panda' (Figure-1) can be seen in the tegmentum region of the pons in the T2 -weighted sequence 9 as seen in our case.
Penicillamine was considered previously the primary anticopper treatment, but now-a-days, it plays only a minor role because of its toxicity and even it often worsens the existing neurologic disease if it is used as the initial therapy. If penicillamine is given, it should always be accompanied by 25 mg/d of pyridoxine. Trientine is a less toxic chelator and it supplants penicillamine when a chelator is indicated. The drug of choice for Wilson's disease with neurologic/ neuropsychiatric symptoms is Ammonium tetrathiomolybdate, but in most of the countries, it is not available commercially and it is still an experimental medicine. For the patients with hepatitis or cirrhosis, without an evidence of a hepatic decompensation or neurologic/psychiatric symptoms, zinc is the therapy of choice, although some advocate the therapy with trientine. Zinc has proven its efficacy in Wilson's disease and it is essentially nontoxic. It produces a negative copper balance by blocking the intestinal absorption of copper, and it induces hepatic metallothionein synthesis, which sequesters the additional toxic copper. All the presymptomatic patients should be treated prophylactically, since the disease is close to 100% penetrant 10, 11 . Our case was treated with oral zinc (as zinc acetate) in high doses (1mg/kg/ dose 8 hourly) and trihexyphenidyl 4mg 8 hourly. After 2 weeks of treatment, an improvement in the symptomatology was seen. Genetic therapy and hepatocyte transplantation represent the future curative treatments for WD, along with the currently available liver transplantation 12 .
Conclusion
Wilson's disease is an uncommon autosomal recessive, metabolic disorder, which is often missed but easily treatable. A high index of suspicion is required while dealing with adolescents and young adults with abnormal movements and neuro-psychiatric abnormalities. A high degree of suspicion and an early detection of WD is difficult but an early initiation of the treatment can prevent a catastrophic outcome.
